[US version] SFDR regulation
This article is only available to professional investors
If you wish to continue, please select a profile
Institutionals and corporate
Désactivé
The glass ceiling, piece by piece
Published on 09/03/2021
Soliane Varlet, Mirova Women Leaders strategy manager, and Mathilde Dufour, Head of Sustainability Research - Listed assets, provide an update on the correlation between diversity and company performance, as well as on Mirova's commitment to gender diversity through its Women Leaders* equity strategy in a documented Q&A.
Sustainable Health - A focus on pharmaceuticals and medical products
Published on 01/03/2021
This document is part of a series published by Mirova to illustrate our approach to sustainability sector-by-sector. We aim to address solutions, risks, and how we optimize impact through investment. This fifth paper focuses on environmental, social and governance issues of pharmaceuticals and medical products.
Sustainable Consumption – A focus on Food & Beverages
Published on 01/03/2021
This document is part of a series published by Mirova to illustrate our approach to sustainability sector-by-sector. We aim to address solutions, risks, and how we optimize impact through investment. This first paper focuses on environmental, social and governance issues in the Food & Beverages industry.
Sustainable Consumption - Focus on Retail, Apparel and Household
Published on 01/03/2021
This document is part of a series published by Mirova to illustrate our approach to sustainability sector-by-sector. We aim to address solutions, risks, and how we optimize impact through investment. This sixth paper focuses on environmental, social and governance issues of retail, apparel and household.
SFDR regulation
This article is not accessible from your country
If you wish to continue, please select your country
Mirova’s natural capital platform selected again for the ImpactAssets 50 list
Published on 23/02/2021
For the fifth consecutive year, Mirova and its 100% owned subsidiary Mirova Natural Capital have been recognized for their approach to impact in natural capital investing and made the ImpactAssets 50’s list.
Mirova and almost 150 institutional investors issue joint call for “fair and equitable” global response to COVID-19
Published on 23/02/2021
Close to 150 institutional investors, representing over US$ 14 trillion in assets under management, are calling for a fair and equitable global response to the pandemic, including through fully financing the Access to COVID-19 Tools (ACT) Accelerator, a global collaboration dedicated to accelerate development, production, and equitable access to COVID-19 tests, treatments, and vaccines. The signatories have also committed to engage with healthcare companies to promote bolder industry actions and therefore contribute to ending the pandemic.
[US version] Our mission
This article is only available to professional investors
If you wish to continue, please select a profile
Our mission
This article is not accessible from your country
If you wish to continue, please select your country
